RxDoctor Payments Data

Jessica Ebey, NP

Family · Bremen, INNPI 1134897242

Payments from drug & device makers

$937in general payments, 2019–2025

Across 51 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$155
  • AbbVie$111
  • Amgen$97
  • AstraZeneca$91
  • Pfizer$76
  • Bayer$58
  • plus $349 from 13 others

What the payments were for

  • Food & beverage$91898%
  • Education$202%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$937 in reported general payments places this provider in the 65th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$23,753
Medicare patients
94
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$30,157
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$15,873
Atorvastatin Calcium134$697
Albuterol Sulfate HfaAlbuterol Sulfate31$596
Levothyroxine Sodium47$482
Omeprazole35$390
Amlodipine Besylate116$373
Duloxetine Hcl29$347
Pantoprazole Sodium42$334
Potassium Chloride13$279
Escitalopram Oxalate14$277
Allopurinol25$240
Metformin Hcl18$233
Metoprolol Succinate25$213
Ezetimibe19$179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$24$30,15730 claims
GSKTrelegy Ellipta$19$15,87319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,392 family providers in Indiana.

Other family in Bremen

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →